We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

16 hedge funds and large institutions have $2.82M invested in ProPhase Labs in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

23% more funds holding

Funds holding: 13 → 16 (+3)

6% less capital invested

Capital invested by funds: $2.98M → $2.82M (-$169K)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$15.9K
2
Renaissance Technologies
Renaissance Technologies
New York
+$11.9K
3
BFA
BlackRock Fund Advisors
California
+$3.71K
4
JP Morgan Chase
JP Morgan Chase
New York
+$507
5
Creative Planning
Creative Planning
Kansas
+$217

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$11.5K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.79K
3
UBS Group
UBS Group
Switzerland
-$1.4K

PRPH Hedge Fund Activity: Q4 2015 in Review

16 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q4 2015, worth a combined $2.82M — down 5.7% from $2.98M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PRPH positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $15.9K. The largest seller was Tower Research Capital (TRC), cutting an estimated $11.5K.

  • 16 institutional investors held ProPhase Labs (PRPH) as of Q4 2015, up from 13 in Q3 2015.
  • Funds reported $2.82M of ProPhase Labs stock for Q4 2015, down 5.7% quarter-over-quarter.
  • 3 funds opened new ProPhase Labs positions in Q4 2015 and 0 closed out, a net change of +3 holders.
  • The largest ProPhase Labs buyer in Q4 2015 was Goldman Sachs, an estimated $15.9K added.
  • The largest ProPhase Labs seller in Q4 2015 was Tower Research Capital (TRC), an estimated $11.5K sold.

Based on aggregated 13F filings for Q4 2015.